1. Home
  2. RTO vs UTHR Comparison

RTO vs UTHR Comparison

Compare RTO & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RTO
  • UTHR
  • Stock Information
  • Founded
  • RTO 1925
  • UTHR 1996
  • Country
  • RTO United Kingdom
  • UTHR United States
  • Employees
  • RTO N/A
  • UTHR N/A
  • Industry
  • RTO Business Services
  • UTHR Biotechnology: Pharmaceutical Preparations
  • Sector
  • RTO Consumer Discretionary
  • UTHR Health Care
  • Exchange
  • RTO Nasdaq
  • UTHR Nasdaq
  • Market Cap
  • RTO 12.0B
  • UTHR 13.8B
  • IPO Year
  • RTO N/A
  • UTHR 1999
  • Fundamental
  • Price
  • RTO $24.98
  • UTHR $397.97
  • Analyst Decision
  • RTO Hold
  • UTHR Strong Buy
  • Analyst Count
  • RTO 1
  • UTHR 15
  • Target Price
  • RTO N/A
  • UTHR $449.13
  • AVG Volume (30 Days)
  • RTO 740.0K
  • UTHR 884.2K
  • Earning Date
  • RTO 07-31-2025
  • UTHR 10-29-2025
  • Dividend Yield
  • RTO 2.27%
  • UTHR N/A
  • EPS Growth
  • RTO N/A
  • UTHR 17.94
  • EPS
  • RTO 0.13
  • UTHR 25.63
  • Revenue
  • RTO $7,581,860,530.00
  • UTHR $3,077,800,000.00
  • Revenue This Year
  • RTO $13.39
  • UTHR $13.89
  • Revenue Next Year
  • RTO $2.81
  • UTHR $5.68
  • P/E Ratio
  • RTO $37.32
  • UTHR $15.54
  • Revenue Growth
  • RTO N/A
  • UTHR 17.62
  • 52 Week Low
  • RTO $19.60
  • UTHR $266.98
  • 52 Week High
  • RTO $27.37
  • UTHR $436.95
  • Technical
  • Relative Strength Index (RSI)
  • RTO 51.51
  • UTHR 54.07
  • Support Level
  • RTO $25.30
  • UTHR N/A
  • Resistance Level
  • RTO $25.97
  • UTHR $407.06
  • Average True Range (ATR)
  • RTO 0.41
  • UTHR 12.93
  • MACD
  • RTO 0.01
  • UTHR -11.50
  • Stochastic Oscillator
  • RTO 59.09
  • UTHR 91.08

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in 89 countries. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: